Evidence map›Paper›PMID 23941823›Full record

ReviewMarine drugs2013

Diversity of secondary metabolites from marine Bacillus species: chemistry and biological activity.

Muhammad Abdul Mojid Mondol, Hee Jae Shin, Mohammad Tofazzal Islam

Abstract readReview
In one paragraph

Review in Marine drugs, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 99 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
99citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

99 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Pathogens (Basel, Switzerland) · 2026
    Review
  5. Article
  6. Bioprospecting Indoor Bacteria Producing Bioactive Metabolites.Environmental microbiology reports · 2026
    Article
  7. Biotechnological potential of marine invertebrate-associated bacteria with antibacterial activity against aquaculture and human pathogens.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2026
    Article
  8. Review
  9. Article
  10. Article
  11. Marine-DerivedMicroorganisms · 2026
    Article
  12. Article
  13. Article
  14. Antagonistic mechanism ofApplied and environmental microbiology · 2025
    Article
  15. Review
  16. Applied and environmental microbiology · 2025
    Article
  17. Review
  18. Article
  19. Article
  20. Article

39 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Muhammad Abdul Mojid MondolSchool of Science and Technology, Bangladesh Open University, Board Bazar, Gazipur 1705, Bangladesh. mondol_sst@yahoo.com
Hee Jae Shin
Mohammad Tofazzal Islam

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Marine Bacillus species produce versatile secondary metabolites including lipopeptides, polypeptides, macrolactones, fatty acids, polyketides, and isocoumarins. These structurally diverse compounds exhibit a wide range of biological activities, such as antimicrobial, anticancer, and antialgal activities. Some marine Bacillus strains can detoxify heavy metals through reduction processes and have the ability to produce carotenoids. The present article reviews the chemistry and biological activities of secondary metabolites from marine isolates. Side by side, the potential for application of these novel natural products from marine Bacillus strains as drugs, pesticides, carotenoids, and tools for the bioremediation of heavy metal toxicity are also discussed.

Indexed as

Drug DesignAnimalsBacillusBiodegradation, EnvironmentalBiological ProductsHumansMetals, HeavyBiological ProductsMetals, Heavy

Identifiers

PMID23941823
PMCPMC3766869

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.